| Dr Matthew J Raider, MD | |
|
645 Saybrook Rd, Middletown, CT 06457-4746 | |
| (860) 767-4024 | |
| (860) 344-9906 |
| Full Name | Dr Matthew J Raider |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 45 Years |
| Location | 645 Saybrook Rd, Middletown, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073562674 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QG0300X | Family Medicine - Geriatric Medicine | 22948 (Connecticut) | Primary |
| 207Q00000X | Family Medicine | 22948 (Connecticut) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Middlesex Hospital Homecare | Middletown, CT | Hospice |
| Middlesex Hospital | Middletown, CT | Hospital |
| Griffin Hospital | Derby, CT | Hospital |
| Apple Rehab Middletown | Middletown, CT | Nursing home |
| Portland Care & Rehab Center, | Portland, CT | Nursing home |
| Apple Rehab Cromwell | Cromwell, CT | Nursing home |
| Entity Name | Middlesex Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851350664 PECOS PAC ID: 5092611731 Enrollment ID: O20031216000518 |
News Archive
However, a fascinating new study posted to the medRxiv* preprint server suggests that such disappointment may have been both premature and unwarranted, based on a re-analysis of over 250 patients on invasive mechanical ventilation (IMV) during the first two months of the pandemic.
Bacteria may play more of a role in people predisposed to obesity than previously thought, according to studies presented today by University of Maryland School of Medicine researchers at the 110th general meeting of the American Society for Microbiology in San Diego.
The European Society for Medical Oncology (ESMO) welcomes the recent proposal by the European Commission aimed at streamlining the process and shortening the timeline surrounding national decisions on pricing drugs and reimbursement of payment made for medicines. This initiative, says ESMO, will facilitate patient access to innovative treatments on an EU-wide level.
Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.
The governing board of the California Institute for Regenerative Medicine unanimously approved this week two grants worth more than $2.2 million to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.
› Verified 2 days ago
| Entity Name | Matthew Raider Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093952194 PECOS PAC ID: 1254495245 Enrollment ID: O20090206000145 |
News Archive
However, a fascinating new study posted to the medRxiv* preprint server suggests that such disappointment may have been both premature and unwarranted, based on a re-analysis of over 250 patients on invasive mechanical ventilation (IMV) during the first two months of the pandemic.
Bacteria may play more of a role in people predisposed to obesity than previously thought, according to studies presented today by University of Maryland School of Medicine researchers at the 110th general meeting of the American Society for Microbiology in San Diego.
The European Society for Medical Oncology (ESMO) welcomes the recent proposal by the European Commission aimed at streamlining the process and shortening the timeline surrounding national decisions on pricing drugs and reimbursement of payment made for medicines. This initiative, says ESMO, will facilitate patient access to innovative treatments on an EU-wide level.
Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.
The governing board of the California Institute for Regenerative Medicine unanimously approved this week two grants worth more than $2.2 million to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.
› Verified 2 days ago
| Entity Name | Claris Health Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356797070 PECOS PAC ID: 5496097396 Enrollment ID: O20190910001348 |
News Archive
However, a fascinating new study posted to the medRxiv* preprint server suggests that such disappointment may have been both premature and unwarranted, based on a re-analysis of over 250 patients on invasive mechanical ventilation (IMV) during the first two months of the pandemic.
Bacteria may play more of a role in people predisposed to obesity than previously thought, according to studies presented today by University of Maryland School of Medicine researchers at the 110th general meeting of the American Society for Microbiology in San Diego.
The European Society for Medical Oncology (ESMO) welcomes the recent proposal by the European Commission aimed at streamlining the process and shortening the timeline surrounding national decisions on pricing drugs and reimbursement of payment made for medicines. This initiative, says ESMO, will facilitate patient access to innovative treatments on an EU-wide level.
Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.
The governing board of the California Institute for Regenerative Medicine unanimously approved this week two grants worth more than $2.2 million to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew J Raider, MD 645 Saybrook Rd, Middletown, CT 06457-4746 Ph: (860) 767-4024 | Dr Matthew J Raider, MD 645 Saybrook Rd, Middletown, CT 06457-4746 Ph: (860) 767-4024 |
News Archive
However, a fascinating new study posted to the medRxiv* preprint server suggests that such disappointment may have been both premature and unwarranted, based on a re-analysis of over 250 patients on invasive mechanical ventilation (IMV) during the first two months of the pandemic.
Bacteria may play more of a role in people predisposed to obesity than previously thought, according to studies presented today by University of Maryland School of Medicine researchers at the 110th general meeting of the American Society for Microbiology in San Diego.
The European Society for Medical Oncology (ESMO) welcomes the recent proposal by the European Commission aimed at streamlining the process and shortening the timeline surrounding national decisions on pricing drugs and reimbursement of payment made for medicines. This initiative, says ESMO, will facilitate patient access to innovative treatments on an EU-wide level.
Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.
The governing board of the California Institute for Regenerative Medicine unanimously approved this week two grants worth more than $2.2 million to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.
› Verified 2 days ago
Mr. Thomas J Mclarney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 High St, Davison Health Center, Middletown, CT 06459 Phone: 860-685-2470 Fax: 860-685-2471 | |
Dr. James Robert Ulager, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Centerpoint Dr Ste 105, Middletown, CT 06457 Phone: 860-215-2295 | |
Kimberly Legere-sharples, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 90 S Main St, Family Practice Group, Middletown, CT 06457 Phone: 860-358-6300 Fax: 860-358-9249 | |
Matthew Huddleston, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 675 Main St, Middletown, CT 06457 Phone: 860-347-6971 Fax: 860-343-7379 | |
Keith Sinusas, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 90 S Main St, Middletown, CT 06457 Phone: 860-344-6300 Fax: 860-344-9249 | |
Jennifer Lyn Sutherland, M.D., M.P.H Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28 Crescent St, Middletown, CT 06457 Phone: 860-358-4820 Fax: 860-358-8661 | |
Alexandra Anne Carlson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28 Crescent St, Middletown, CT 06457 Phone: 860-358-4798 |